Gener8 acquired RND, expanding into software development for the life sciences
SUNNYVALE, California, December 9, 2021 / PRNewswire / – Gener8 LLC (“Gener8”), a holding company of Sverica Capital Management LP (“Sverica”), today announced that it has completed the acquisition of RND Group (“RND”), a leading provider of software development focused on medical devices and life science products, based at Indianapolis, Indiana.
With the acquisition of RND, Gener8 adds full lifecycle software development capabilities, including cloud solutions, verification and validation, quality system compliance, LIS / EHR integration and more. The company has assembled a protocol library which serve to speed up the development process by taking advantage of predefined core functionalities. While Gener8 already provides turnkey instrument and consumable solutions, as well as the firmware that accompanies it, the acquisition of RND allows Gener8 to extend its services outside the instrument to the associated software.
âRND is a world-class medical software development operation with a top-notch customer base and a unique set of capabilities,â said Jerry Jurkiewicz, CEO of Gen8. “We have already partnered on several programs, and the combination’s value proposition has resonated strongly with clients.”
âWe are delighted to join Jerry and the rest of the Gener8 team. From our first interactions, it was clear that there would be a great fit between our companies and, more importantly, that bringing our capabilities together under one roof would be a real winner. for customers, “added Tim DeFrench, Founder and President of RND.
Generator8, founded in 2002, is a leading provider of turnkey design and manufacturing services, specializing in high complexity products, primarily for medical devices and diagnostic applications. Gener8 has state-of-the-art facilities and a world-class team of engineers with over 40 doctorates spanning a multitude of disciplines including electrical, mechanical, software, optical and systems engineering. For more information, please visit www.gener8.net.
About Sverica Capital Management
Sverica Capital Management is a leading growth-oriented private equity firm that has raised more than $ 1.1 billion on five funds. The Company actively acquires, invests and builds companies that are or could become leaders in their industry. Since its inception, Sverica has followed a ‘business builder’ approach to investing and plays an active supporting role in the companies in its portfolio. Sverica devotes significant time and internal resources to helping its management teams develop and execute growth strategies and proactively seeks levers to accelerate growth by reinvesting in these companies. Sverica is a firm believer in building collaborative businesses that can last for the long term by starting with a solid foundation and bringing in the right people and the right game plan to generate reinvestments and ultimately solid returns for our people. investors. For more information, please visit www.sverica.com.
SOURCE Gener8, LLC